Evidence map›Paper›PMID 32171908›Full record

ReviewBiochimica et biophysica acta. Molecular and cell biology of lipids2020

S1P and plasmalogen derived fatty aldehydes in cellular signaling and functions.

David L Ebenezer, Panfeng Fu, Ramaswamy Ramchandran, Alison W Ha, Vijay Putherickal, Tara Sudhadevi, Anantha Harijith, Fabian Schumacher, Burkhard Kleuser, Viswanathan Natarajan

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta. Molecular and cell biology of lipids, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Plasmalogen, a glycerophospholipid crucial forApplied and environmental microbiology · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. NOX4 MediatesAntioxidants (Basel, Switzerland) · 2021
    Article
  18. Worms, Fat, and Death:Metabolites · 2021
    Review
  19. Review
  20. Lysophospholipids in Lung Inflammatory Diseases.Advances in experimental medicine and biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

David L EbenezerDepartment of Pharmacology, University of Illinois, Chicago, IL, United States of America.
Panfeng FuDepartment of Pharmacology, University of Illinois, Chicago, IL, United States of America.
Ramaswamy RamchandranDepartment of Pharmacology, University of Illinois, Chicago, IL, United States of America.
Alison W HaDepartment of Biochemistry and Molecular Genetics, University of Illinois, Chicago, IL, United States of America.
Vijay PutherickalDepartment of Pharmacology, University of Illinois, Chicago, IL, United States of America.
Tara SudhadeviDepartment of Pediatrics, University of Illinois, Chicago, IL, United States of America.
Anantha HarijithDepartment of Pediatrics, University of Illinois, Chicago, IL, United States of America.
Fabian SchumacherInstitute of Nutritional Sciences, University of Potsdam, Germany; Department of Molecular Biology, University of Duisburg-, Essen, Germany.
Burkhard KleuserInstitute of Nutritional Sciences, University of Potsdam, Germany.
Viswanathan NatarajanDepartment of Pharmacology, University of Illinois, Chicago, IL, United States of America; Department of Medicine, University of Illinois, Chicago, IL, United States of America. Electronic address: visnatar@uic.edu.

Funding

TRPC6 Regulation of Lung Endothelial Barrier FunctionP01HL060678 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2000 to 2020
$40.1M
Structure-Function Analysis of nmMLCK in EC Barrier ResponsesP01HL126609 · NHLBI · UNIVERSITY OF FLORIDA · PI Joe G. N. Garcia · 2016 to 2026
$24.4M
NHLBI NIH HHS P01 HL060678NHLBI NIH HHS P01 HL126609
6 · The paper itself

Abstract

Long-chain fatty aldehydes are present in low concentrations in mammalian cells and serve as intermediates in the interconversion between fatty acids and fatty alcohols. The long-chain fatty aldehydes are generated by enzymatic hydrolysis of 1-alkyl-, and 1-alkenyl-glycerophospholipids by alkylglycerol monooxygenase, plasmalogenase or lysoplasmalogenase while hydrolysis of sphingosine-1-phosphate (S1P) by S1P lyase generates trans ∆2-hexadecenal (∆2-HDE). Additionally, 2-chloro-, and 2-bromo- fatty aldehydes are produced from plasmalogens or lysoplasmalogens by hypochlorous, and hypobromous acid generated by activated neutrophils and eosinophils, respectively while 2-iodofatty aldehydes are produced by excess iodine in thyroid glands. The 2-halofatty aldehydes and ∆2-HDE activated JNK signaling, BAX, cytoskeletal reorganization and apoptosis in mammalian cells. Further, 2-chloro- and 2-bromo-fatty aldehydes formed GSH and protein adducts while ∆2-HDE formed adducts with GSH, deoxyguanosine in DNA and proteins such as HDAC1 in vitro. ∆2-HDE also modulated HDAC activity and stimulated H3 and H4 histone acetylation in vitro with lung epithelial cell nuclear preparations. The α-halo fatty aldehydes elicited endothelial dysfunction, cellular toxicity and tissue damage. Taken together, these investigations suggest a new role for long-chain fatty aldehydes as signaling lipids, ability to form adducts with GSH, proteins such as HDACs and regulate cellular functions.

Indexed as

Signal TransductionAldehyde-LyasesAldehydesAnimalsHistone DeacetylasesHumansPlasmalogens2-hexadecenalAldehyde-LyasesAldehydesHistone DeacetylasesPlasmalogenssphingosine 1-phosphate lyase (aldolase)HexadecenalLong-chain fatty aldehydesLysoplasmalogenasePlasmalogenaseS1PS1P Lyase

Identifiers

PMID32171908
PMCPMC7214093

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.